Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults
Clinical trial NCT03135028 · TERMINATED
Trial details
- NCT number
- NCT03135028
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-19
- Primary completion
- 2019-02-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.